Skip to main content
Share

World's leading clinical conference on bone, joint and muscle health

Programme

Go to Sponsored Sessions

Thursday April 11th - GMT Time zone

01:00 - 23:59
WCO-IOF-ESCEO
16:30 - 19:15
Auditorium A
WCO-IOF-ESCEO - OPENING CEREMONY Chairpersons : John A. Kanis & Jean-Yves Reginster
16:30
Auditorium A
Best clinical papers published in 2023 René Rizzoli
17:10
Auditorium A
Opening Cyrus Cooper
17:15
Auditorium A
Bone Health of Older People: An Emerging Public Health Priority Anshu Banerjee
17:25
Auditorium A
Presentation of the ESCEO-Islene Araujo de Carvalho Award Anshu Banerjee & Jean-Yves Reginster
17:30
Auditorium A
IOF 2023 Highlights Philippe Halbout
17:35
Auditorium A
ESCEO 2023 Highlights Olivier Bruyère
17:40
Auditorium A
Artificial intelligence, a tribute to Alan Turing Nicholas R. Fuggle
18:10
Auditorium A
Diseases represented in paintings of the Renaissance and Baroque Period René Rizzoli
18:40
Auditorium A
Tribute to Professor Cyrus Cooper Nicholas Harvey
18:50
Auditorium A
Awards Presentation
  • 18:50 Presentation of the IOF President's Award Nicholas Harvey
  • 18:55 Presentation of the 2024 ESCEO Medal of Excellence Jean-Yves Reginster
  • 19:00 Presentation of the 2024 IOF CSA Medal of Achievement Eugene V. McCloskey
19:15 - 20:15
Welcome Cocktail

Friday April 12th - GMT Time zone

08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Non-Sponsored Symposia
08:00
MR1
Treatment failure: a bad day at the office ? Chairperson : Michael McClung
  • Unmet goals of treated patients Michael McClung
  • Improving efficacy after poor outcomes Bruno Muzzi Camargos
  • Clinical perspectives after a fracture: could it be any worse? Geraldine Altamar Canales
08:00
MR2
Psoriatic disease. A multifaceted disease with musculoskeletal manifestations. Emerging therapies Chairperson : Panagiotis Athanassiou
  • Psoriatic disease: Musculoskeletal manifestations Lambros Athanassiou
  • Psoriatic disease: Comorbidities Ifigenia Kostoglou-Athanassiou
  • Psoriatic disease: Psychosocial implications Yannis Athanassiou
  • Psoriatic disease and rehabilitation Yannis Dionyssiotis
  • Psoriatic disease: Current treatment and emerging therapies Panagiotis Athanassiou
08:00
MR3
Digital health interventions for engaging older adults in exercise – What has been effective and what do consumers want? Chairperson : Mylene Aubertin-Leheudre
  • Implementing physical activity for community-dwelling seniors during periods of isolation Fanny Buckinx
  • Short- and long-term effects of 4 online remote physical activity interventions on physical performances during isolation periods in community-dwelling older adults Mylene Aubertin-Leheudre
  • Understanding older adults’ preferences for engaging in remote interventions for improving physical function: The RAMP international consumer Delphi process David Scott
08:00
MR4
Practical ways to prevent fractures in older adults through focused geriatric assessment Chairpersons : Alfonso J. Cruz-Jentoft & Antonio Cherubini
  • How can the recent World Falls Guidelines be implemented to reduce fracture risk in older people Tahir Masud
  • Screening frailty easily in practice: Validation of Simpler Fried Frailty Scale in different European Countries Fatma Ozge Kayhan
  • Can and how medication review helps us preventing further fractures? Gulistan Bahat
08:00
MR5
Beyond FRAX: important but commonly overlooked risk factors Chairperson : Robert Blank
  • Virtually all fracture sites are associated with adverse post-fracture outcomes Jacqueline R. Center
  • Association between Specific Multimorbidity clusters and the risk of Fracture and Post-Fracture Consequences Thach Tran
  • Self-assessed limited mobility is associated with increased fracture risk in both women and men Dana Bliuc
08:00
MR6
Overcoming the limitations of universal vitamin D cut-offs through a novel metabolic approach Chairperson : Markus Herrmann
  • Functional Assessment of Vitamin D Status by a Novel Metabolic Approach Markus Herrmann
  • 1,25(OH)2D and 1,24,25(OH)3D – expanding our knowledge on vitamin D catabolism beyond VMR Etienne Cavalier
08:00
MR7
The significance of quality indicators in Latin America Chairperson : Juan Carlos Viveros García
  • The Burden of Hip Fractures and the Need for Quality Roberto Enrique Lopez Cervantes
  • Key Quality Indicators for Hip Fracture Care: What to Measure and Why José Francisco Torres Naranjo
  • Implementing Quality Indicators in National Healthcare Systems: Challenges and Success Stories Juan Carlos Viveros García
08:00
MR8
The role of hormones in women’s bone health and wellbeing Chairpersons : Maria Celeste Osorio Wender & Adriana Orcesi Pedro
  • Bone health and hormonal contraception Rogério Bonassi Machado
  • How to manage the early negative impact of premature ovarian insufficiency on bone health? Jose Maria Soares Júnior
  • Bone health and osteoporosis screening in gynecologic cancer survivors Adriana Orcesi Pedro
  • Characterizing body composition and bone health in transgender individuals receiving gender-affirming hormone therapy Edson Santos Ferreira Filho
09:00 - 10:30
Auditorium A
Scientific Session I Chairpersons : Maria Luisa Brandi & René Rizzoli
09:00
Auditorium A
Plenary Lecture 1 Fracture prevention: time to move beyond the primary/secondary dichotomy? Eugene V. McCloskey
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts OC1: COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS BISPHOSPHONATES AMONG TREATMENT-EXPERIENCED POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE U.S. MEDICARE PROGRAM Presenting author: V. C. Brunetti Authors: J. R. Curtis, T. Aurora, Y. Liu, T.-C. Lin, L. Spangler, R. K. Stad, M. Mcdermott and B. D. Bradbury
09:40
Auditorium A
Oral communication selected from abstracts OC2: BMD RESPONSES AT THE LUMBAR SPINE AND TOTAL HIP IN PATIENTS RECEIVING ROMOSOZUMAB, DENOSUMAB AND ALENDRONATE: A POST HOC ANALYSIS OF THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS Presenting author: B. Langdahl Authors: F. Cosman, L. Gifre, K. Poole, F. Thomasius, P. R. Ebeling, J. P. van den Bergh, E. M. Lewiecki, J. Timoshanko, Z. Wang and C. Libanati
09:50
Auditorium A
Oral communication selected from abstracts OC3: CARDIOVASCULAR SAFETY OF ROMOSOZUMAB IN OSTEOPOROSIS PATIENTS: A TRINETX MULTI-INSTITUTIONAL RESEARCH NETWORK ANALYSIS Presenting author: C.-R. Li Authors: H.-T. Lee and Y.-L. Deng
10:00
Auditorium A
Oral communication selected from abstracts OC4: THE COMPARATIVE EFFECTIVENESS AND CARDIOVASCULAR SAFETY OF ABALOPARATIDE AND TERIPARATIDE IN POSTMENOPAUSAL WOMEN NEW TO ANABOLIC THERAPY: UPDATE OF A REAL-WORLD RETROSPECTIVE Presenting author: J.-Y. Reginster Authors: R. Rizzoli, B. Cortet, Y. Wang, J. Chiodo and B. H. Mitlak
10:10
Auditorium A
Oral communication selected from abstracts OC5: ZOLEDRONIC ACID AND DENOSUMAB ARE COMPARABLE IN DIABETIC OSTEOPOROTIC PATIENTS: A POPULATION-BASED COHORT STUDY Presenting author: V. Rouach Authors: H. Gortler, Y. Greenman, G. Chodick and I. Goldshtein
10:20
Auditorium A
Oral communication selected from abstracts OC6: ANTIRESORPTIVE MEDICATION-RELATED JAW OSTEONECROSIS: AN EUROPEAN EUDRAVIGILANCE DATABASE-BASED RETROSPECTIVE COHORT STUDY Presenting author: S. Ferreira Azevedo Authors: C. Pinto Oliveira, A. R. Prata, I. Cunha and A. Barcelos
10:30 - 12:10
Auditorium A
Scientific Session II Chairpersons : Manju Chandran & Nicholas Harvey
10:30
Auditorium A
Presentation of the ESCEO-IOF Pierre Delmas Medal Jean-Yves Reginster & Nicholas Harvey
10:40
Auditorium A
Plenary Lecture 2 Optimization of lifelong osteoporosis management Michael McClung
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts OC7: CLINICAL IMPACT OF ACUTE SYMPTOMATIC VERTEBRAL FRACTURES IN THE UNITED STATES: AN OBSERVATIONAL STUDY Presenting author: N. Binkley Authors: M. Mcdermott, E. Yeh, J. Lane, J. Cheung, M. Amet and F. Cosman
11:20
Auditorium A
Oral communication selected from abstracts OC8: MULTIMORBIDITY AND RISK OF FALLS, FRACTURES, AND JOINT REPLACEMENTS OVER TWO DECADES: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: C. Pearse, R. Rambukwella, K. A. Ward, C. Cooper and E. M. Dennison
11:30
Auditorium A
Oral communication selected from abstracts OC9: TEN-YEAR FOLLOW-UP OF FRACTURE RISK IN A SYSTEMATIC POPULATION-BASED SCREENING PROGRAMME: THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) RANDOMISED TRIAL Presenting author: K. H. Rubin Authors: T. G. Petersen, B. Abrahamsen, M. Højberg, M. J. Rothmann, T. Holmberg, J. Gram, M. Beck, K. E. Akesson, K. M. Javaid and A. P. Hermann
11:40
Auditorium A
Oral communication selected from abstracts OC10: ELEVATED FRACTURE RISK IN A DANISH COHORT WITH TYPE 2 DIABETES MELLITUS AND MICROVASCULAR DISEASES Presenting author: M. Nasser Authors: T. Grønborg, F. Kristensen, R. Thomsen, A. Vaag, J. Nielsen, K. Højlund, M. Olsen, P. Vestergaard, R. Eastell and M. Frost
11:50
Auditorium A
Oral communication selected from abstracts OC11: ALARMING INCREASE IN BURDEN OF SPINAL FRACTURE IN THE MIDDLE EAST AND NORTH AFRICA: A 30-YEAR SECONDARY ANALYSIS OF THE GLOBAL BURDEN OF DISEASE STUDY 2019 Presenting author: A. Azarboo Authors: A. H. Hoveidaei, A. Ghaseminejad-Raeini, M. S. Khonji, S. H. Hosseini-Asl and K. Pirahesh
12:00
Auditorium A
Oral communication selected from abstracts OC12: DIMINISHING RETURNS OF FALL PREVENTION ON HIP FRACTURE WITH AGE Presenting author: M. Lorentzon Authors: H. Johansson, N. Harvey, E. Liu, M. Schini, L. Vandenput, E. V. McCloskey and J. A. Kanis
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
Meet-The-Expert Session
14:00
MR1
Complex osteoporosis: case histories Elaine M. Dennison
14:00
MR2
Guidelines for management of hypoparathyroidism Maria Luisa Brandi
14:00
MR3
Machine learning and computer vision - the future of fracture risk assessment? Nicholas R. Fuggle
14:00
MR4
An integrated approach to nutrition in musculoskeletal disease Nicola Veronese
14:00
MR6
‘omics in the future of bone health assessment Etienne Cavalier
14:00
MR7
Guidelines for management of primary hyperparathyroidism Marise Lazaretti-Castro
14:00
MR8
How can we optimize fracture healing? Andreas Kurth
14:00 - 15:00
Podium
Oral presentations of selected posters Chairperson : K. A. Ward
14:00
Podium
P683 EFFICACY AND SAFETY OF CT-P41, A PROPOSED DENOSUMAB BIOSIMILAR, COMPARED TO REFERENCE DENOSUMAB (PROLIA) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS Presenting author: J.-Y. Reginster Authors: E. Czerwinski, A. Strzelecka, K. Szymanowski, S. Postol, A. Poder, J. Supronik, K. Wilk, P. Borowy, T. Budlewski, M. Janowska-Maus, J. Kwiatek, S. H. Kim, J. H. Suh, N. R. Han, N. H. Kim, S. H. Bae and S. L. Silverman
14:06
Podium
P1394 BISPHOSPHONATES SHOW NO ASSOCIATION WITH PREVENTING, SLOWING, OR DELAYING RADIOGRAPHIC CHANGES AND PAIN IN HIP OSTEOARTHRITIS: A FOUR-YEAR STUDY IN FEMALE ADULTS USING DATA FROM THE OSTEOARTHRITIS INITIATIVE STUDY Presenting author: Z. Salis
14:12
Podium
P504 ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS Presenting author: G. Adami Authors: A. Fassio, D. Gatti, O. Viapiana, C. Benini and M. Rossini
14:18
Podium
P512 RELATIONSHIPS BETWEEN SELF-PERCEIVED FRACTURE RISK AND FAMILY HISTORY IN THE HERTFORDSHIRE INTERGENERATIONAL STUDY – THE SAME OR DIFFERENT TO PERCEPTIONS REGARDING HEART DISEASE RISK? Presenting author: G. Bevilacqua Authors: L. D. Westbury, C. Cooper and E. M. Dennison
14:24
Podium
P674 TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL Presenting author: C. Swearingen Authors: Y. Yazici, J. Tambiah and P. Conaghan
14:30
Podium
P1167 EFFECT OF ROMOSOZUMAB ON TISSUE THICKNESS–ADJUSTED TRABECULAR BONE SCORE (TBSTT) IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND DIABETES: RESULTS FROM THE ARCH STUDY Presenting author: S. Ferrari Authors: D. Betah, R. Feldman, B. Langdahl, M. Oates, J. Timoshanko, Z. Wang and R. Dhaliwal
14:36
Podium
P488 RELATIONSHIPS BETWEEN EARLY LIFE FACTORS AND OSTEOARTHRITIS PAIN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: F. J. Kirkham-Wilson Authors: L. D. Westbury, N. R. Fuggle, F. Laskou, C. Cooper and E. M. Dennison
14:42
Podium
P935 INCREASED BONE MARROW ADIPOSITY IS RELATED TO HIGHER FRACTURE RISK AND LOWER BONE MINERAL DENSITY IN OLDER SWEDISH WOMEN Presenting author: M. Zoulakis Authors: K. F. Axelsson, H. Litsne, L. Johansson and M. Lorentzon
14:48
Podium
P321 HEALTH-RELATED QUALITY OF LIFE IN SARCOPENIA: CONTENT VALIDITY OF THE SARQOL QUESTIONNAIRE. Presenting author: C. Demonceau Authors: B. Voz, O. Bruyère, J.-Y. Reginster and C. Beaudart
14:54
Podium
P360 WHAT IS THE EFFECT OF HORMONE REPLACEMENT THERAPY (HRT) ON PREVALENCE, INCIDENCE, AND SEVERITY OF OSTEOARTHRITIS (OA) OF THE KNEE, HIP AND HANDS? A SYSTEMATIC REVIEW Presenting author: C. W. Hillman Authors: K. Marino, O. O'Sullivan, S. Kluzek, R. Atkinson and A. Hassan
14:00 - 15:00
Poster Area
Poster Viewing Session I
14:00 - 15:00
Auditorium B
Sponsored Meet-The-Expert Session

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
MR5
WHO SYMPOSIUM WHO Symposium on Bone Health and Ageing Chairpersons : Anshu Banerjee & René Rizzoli
  • Overview of WHO Technical Work on Bone Health and Ageing Jothees Amuthavalli Thiyagarajan
  • Systematic review of Measurement Properties of instruments to measure the quality of life of older persons with Sarcopenia and Osteoporosis Shaun Sabico
  • Systematic Review of Measurement Properties of Instruments to Assess Risk of Fracture in Older Persons – An update Germain Honvo
  • WHO Global Report on Fractures among Older Persons: An overview Jothees Amuthavalli Thiyagarajan
  • Reflections Jean-Yves Reginster
15:00 - 17:00
Auditorium A
Scientific Session III Chairpersons : Jean-Marc Kaufman & Patricia Clark
15:00
Auditorium A
Plenary Lecture 3 Unravelling the vitamin D megatrial conundrum Bess Dawson-Hughes
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts OC13: PREDICTING THE ONSET OF END-STAGE KNEE OSTEOARTHRITIS OVER TWO- AND FIVE-YEARS USING MACHINE LEARNING Presenting author: Z. Salis Authors: J. Driban and T. McAlindon
15:40
Auditorium A
Oral communication selected from abstracts OC14: MILD COGNITIVE IMPAIRMENT PREDICTS THE ONSET OF SARCOPENIA: A LONGITUDINAL ANALYSIS FROM THE ENGLISH LONGITUDINAL STUDY ON AGEING Presenting author: N. Veronese Authors: F. S. Ragusa, L. Dominguez, L. Smith and F. Bolzetta
15:50
Auditorium A
Oral communication selected from abstracts OC15: COMPARATIVE EFFECTIVENESS OF YOGA AND STRENGTHENING EXERCISE FOR TREATING KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED TRIAL (YOGA TRIAL) Presenting author: B. J. Abafita Authors: D. Aitken, A. Singh, S. Moonaz, C. Ding, S. Drummen, L. Blizzard, A. J. Palmer, G. Jones, K. L. Bennell and B. E. Antony
16:00
Auditorium A
Oral communication selected from abstracts OC16: RADIOGRAPHIC AND PAIN OUTCOMES FROM A PHASE 3 EXTENSION STUDY (OA-07) EVALUATING THE SAFETY AND EFFICACY OF REPEAT LORECIVIVINT INJECTIONS OVER 3 YEARS IN SUBJECTS WITH SEVERE KNEE OSTEOARTHRITIS Presenting author: J. Tambiah Authors: Y. Yazici, C. Swearingen and T. McAlindon
16:10
Auditorium A
Oral communication selected from abstracts OC17: CURRENT SARCOPENIA DEFINITIONS ARE NOT VALID FOR PREDICTING FALLS AND POOR PHYSICAL FUNCTION IN URBAN DWELLING OLDER ADULTS IN SOUTH AFRICA, THE GAMBIA AND ZIMBABWE: RESULTS FROM THE MUFASSA STUDY Presenting author: K. A. Ward Authors: L. K. Micklesfield, L. Gates, T. Manyanga, M. K. Jallow, B. Cassim, Y. Madela, S. Crozier, C. Cooper, A. J. Burton, H. Wilson, R. A. Ferrand and C. L. Gregson
16:20
Auditorium A
Oral communication selected from abstracts OC18: INCREASED RISK OF STROKE IN PATIENTS WITH OSTEOARTHRITIS IN A PROSPECTIVE COHORT OF MEN : THE STRAMBO STUDY Presenting author: M. A. Auroux Authors: R. Chapurlat and P. Szulc
16:30
Auditorium A
Plenary Lecture 4 Bone, biochemistry and beyond: new paradigms in CKD MBD Peter R. Ebeling
Have a sneak peek
15:00 - 16:45
MR5
Committee of National Societies Special Plenary Session Chairperson : Famida Jiwa
15:00
MR5
Tribute to Professor Gemma ADIB, a pioneer in the fight against osteoporosis in the Middle East region Basel Masri
15:10
MR5
OCs1: VARIATIONS IN HOSPITAL LENGTH OF STAY AND PERFORMED SURGICAL PROCEDURES AFTER HIP FRACTURES Presenting author: A. I. Gasparik Authors: L. Lorenzovici, M. Cevei, D. M. Farcas and D. Stoicanescu
15:18
MR5
OCs2: LESSONS FROM RICO: RISK COMMUNICATION IN OSTEOPOROSIS STUDY Presenting author: C. Beaudart Authors: M. Sharma, S. L. Silverman and M. Hiligsmann
15:26
MR5
OCs3: FROM PIXELS TO PREVENTION: AI-POWERED DIGITAL RADIOGRAMMETRY DEMOCRATIZES OSTEOPOROSIS DIAGNOSIS Presenting author: F. Shau-Huai Authors: L. Cheng Wei, L. Chia-Hung, J. Yu-Ming, T. Qingzong and L. Yen-Jun
15:34
MR5
OCs4: VERTEBRAL FRACTURES BY DXA: IS THE CURRENT DEFINITION ADEQUATE? Presenting author: J. L. A. Morales Torres Authors: J. Romero Ibarra and J. Morales Vargas
15:42
MR5
OCs5: ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: G. Bevilacqua, C. Cooper and E. M. Dennison
15:50
MR5
Presentation of the IOF Committee of National Societies Medal Famida Jiwa
16:00
MR5
OCs6: BONE MINERAL DENSITY AND HAND GRIP STRENGTH IN POSTMENOPAUSAL WOMEN WITH FOREARM FRACTURES Presenting author: N. Grygorieva Authors: I. Stets, A. Iniushyna, D. Kurylo and A. Musiienko
16:08
MR5
OCs7: ORTHOGERIATRIC CO-MANAGEMENT FOR OLDER PATIENTS WITH A MAJOR OSTEOPOROTIC FRACTURE: AN OBSERVATIONAL PRE-POST STUDY Presenting author: S. Janssens Authors: A. Sermon, M. Deschodt, K. Fagard, M. Cerulus, H. Cosyns, J. Flamaing, M. Herteleer and M. Dejaeger
16:16
MR5
OCs8: UNITING THE DICHOTOMY BETWEEN PRIMARY AND SECONDARY PREVENTION OF OSTEOPOROSIS – A COMMUNITY- BASED INTERVENTION Presenting author: Y. El Miedany Authors: A. Gadallah, M. Sarhan, M. Elgaafary and A. Ahmed
16:24
MR5
OCs9: HAND GRIP STRENGTH IN PATIENTS WHO DIAGNOSED WITH TYPE 2 DIABETES MELLITUS IN MONGOLIAN FAMILY HEALTH CENTER Presenting author: M. Jaalkhorol Authors: E. Jamsranjav, E. Radnaa, B. Bat-Orgil, G. Ochirdorj and O. Bold
16:32
MR5
OCs10: MACHINE LEARNING TO CHARACTERIZE BONE BIOMARKERS PROFILE IN RHEUMATOID ARTHRITIS Presenting author: G. Adami Authors: D. Gatti, C. Benini, O. Viapiana, A. Fassio and M. Rossini
17:00 - 18:30
Auditorium A
Sponsored Satellite Symposium

* See details on the Sponsored Satellite Symposia page

18:30 - 19:30
Non-Sponsored Symposia
18:30
MR1
Clinical management of patients on anabolic therapy for osteoporosis Chairperson : Bruno Muzzi Camargos
  • Follow-up through imaginological assessment: aDXA, TBS, RX, VFA, 3D-DXA and QCT Bruno Muzzi Camargos
  • Clinical management of patients under anabolic therapy Angela M. Cheung
18:30
MR2
Update in diagnosis and management of fibromyalgia syndrome on the basis of evidence based medicine Chairpersons : Fitnat Dincer & Andreas Winkelmann
  • Update in Diagnosis of Fibromyalgia Syndrome on the Basis of Evidence based Medicine Andreas Winkelmann
  • Update in Pharmacological Management of FMS on the Basis of Evidence Based Medicine Fitnat Dincer
  • Update in Non -Pharmacological Management of FMS on the Basis of Evidence Based Medicine Daiana Popa
18:30
MR3
Skeletal Fragility: new era in the management of the CKD patients Chairpersons : Hanne Jorgensen & Serge Ferrari
  • KDIGO: what’s news in CKD-MBD Thomas Nickolas
  • The Association between Vertebral Fractures and Vascular Calcifications in Patients without and with CKD Maria Fusaro
  • Bone Biopsy: How, When and Why perform it in CKD patients Mathias Haarhaus
18:30
MR4
Vitamin D in rheumatic diseases Chairpersons : Osvaldo Daniel Messina & Jorge L. A. Morales Torres
  • Epidemiology of VD in Rheumatic diseases Patricia Clark
  • Vitamin D and Systemic Lupus Erythematosus, Antiphospholipid syndrome, and Systemic Sclerosis Jorge L. A. Morales Torres
  • Vitamin D levels in patients with rheumatoid arthritis Osvaldo Daniel Messina
18:30
MR7
Artificial intelligence in osteoporosis: including a case study of vertebral fracture detection Chairpersons : Nicholas R. Fuggle & Kassim M. Javaid
  • What is ‘Clinical AI’ and how is it used in Osteoporosis? Nicholas R. Fuggle
  • Ethical Considerations when using of AI in Clinical Practice Ethics Team - The Alan Turing Institute
  • Artificial Intelligence in Osteoporosis: including a case study of vertebral fracture detection: AI for vertebral fracture screening: A UK perspective – Findings of the ADOPT study Kassim M. Javaid

Saturday April 13th - GMT Time zone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR3
Osteoporosis and atherosclerotic heart disease Chairperson : Peter R. Ebeling
  • Vascular-Bone Nexus: A narrative review of the Evidence from epidemiological Studies and randomized controlled Trials Joshua Lewis
  • A model for Bone as the Source of Calcification in Atherosclerotic Heart Disease Gordon Klein
08:00
MR4
Insights into ageing: lessons from the senior and sarcophage cohorts on frailty and sarcopenia Chairperson : Olivier Bruyère
  • SENIOR contributions to frailty, nutrition and physical activity Fanny Buckinx
  • SarcoPhAge contributions to sarcopenia, malnutrition and quality of life Charlotte Beaudart
  • The SENIOR and SarcoPhAge cohorts to study COVID and long-term mortality Céline Demonceau
  • Conclusion and questions Olivier Bruyère
08:00
MR5
Capture the Fracture® : global perspectives and experience Chairpersons : Nicholas Harvey & Maria Luisa Brandi
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Asia-Pacific Manju Chandran
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Europe Maria Luisa Brandi
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – North America Famida Jiwa
  • Global Experiences in FLS Implementation and secondary fracture prevention in policy – Latin America Patricia Clark
08:00
MR6
The fatal attraction of cancer and bone Chairpersons : Janet Brown & Peyman Hadji
  • Treatment induced Osteoporosis in women with breast cancer Peyman Hadji
  • Treatment induced Osteoporosis in men with prostate cancer Janet Brown
  • Current guideline dependent treatment of bone metastasis Cyrille Confavreux
08:00
MR7
Sarcopenia state-of-the-art: components, definitions and global impact Chairpersons : Elaine M. Dennison & Elizabeth M. Curtis
  • Sarcopenia components and definitions: prevalence, agreement and predictive capacity regarding mortality Leo D. Westbury
  • Sarcopenia components and definitions as predictors of fracture risk Nicholas Harvey
  • Prevalence and burden of sarcopenia in sub-Saharan Africa Kate A. Ward
08:00
MR8
Assessment of risk of falls and fracture in older women: project in primary care in women’s health Chairperson : Bruno Muzzi Camargos
  • Construction of a project to assess the risk of falls based on women’s musculoskeletal physiology Oslei de Matos
  • Development of a fall risk assessment protocol based on musculoskeletal and comprehensive assessment: protocols and main results Brenda Lenardt
08:00 - 09:00
MR2
DVO-ESCEO Joint Symposium The DVO Concept to provide Care for Patients with Osteoporosis and Bone Diseases in German speaking countries Chairpersons : John A. Kanis & Ralf Schmidmaier
  • The new DVO guidelines for osteoporosis 2023 – a paradigm change for the german speaking countries Friederike Thomasius
  • Disease Management Program Osteoporosis - a politically decided structured care program for Germany Andreas Kurth
  • A new case finding algorithm according to fracture risk Claus Glüer
  • Medical education in Osteology care: from basic research to clinical competence certification Ralf Schmidmaier
09:00 - 10:30
Auditorium A
Scientific Session IV Chairpersons : Bess Dawson-Hughes & Olivier Bruyère
09:00
Auditorium A
Plenary Lecture 5 Bone resorption inhibitors beyond the skeleton Bo Abrahamsen
Have a sneak peek
09:30
Auditorium A
Oral communications selected from abstracts
09:30
Auditorium A
Oral communication selected from abstracts OC19: DXA-DERIVED HIP SHAPE IS PREDICTIVE OF HIP FRACTURE: A LONGITUDINAL STUDY FROM UK BIOBANK Presenting author: S. Scott Authors: A. Hashmi, R. Ebsim, F. R. Saunders, J. S. Gregory, R. M. Aspden, C. Lindner, T. Cootes, N. Harvey, J. H. Tobias, B. G. Faber and R. Beynon
09:40
Auditorium A
Oral communication selected from abstracts OC20: GREATER THIGH MUSCLE MASS MEASURED BY MRI IS ASSOCIATED WITH REDUCED INCIDENT FRACTURE RISK IN WOMEN, BUT NOT MEN: FINDINGS FROM THE UK BIOBANK Presenting author: E. M. Curtis Authors: S. D'Angelo, R. J. Moon, J. Paccou, N. R. Fuggle, E. M. Dennison, C. Cooper, K. A. Ward and N. Harvey
09:50
Auditorium A
Oral communication selected from abstracts OC21: HIP GEOMETRY AND FRACTURE AMONG IRISH MEN AND WOMEN: THE DXA HIP PROJECT Presenting author: M. Ebrahimiarjestan Authors: E. E., A. Brennan, L. Yang, T. Wang, C. Silke, M. O'Sullivan, M. Dempsey, M. Yu, J. Carey, G. O'Malley, A. Mcpartland and B. Rooney
10:00
Auditorium A
Oral communication selected from abstracts OC22: COST-EFFECTIVENESS OF RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS) FOR THE DIAGNOSIS OF OSTEOPOROSIS IN THE UNITED STATES Presenting author: M. Hiligsmann Author: J.-Y. Reginster
10:10
Auditorium A
Oral communication selected from abstracts OC23: EXTERNAL VALIDATION OF AI-DRIVEN BONE FRAGILITY DETECTION IN RADIOGRAPHS FROM MULTINATIONAL COHORTS Presenting author: M. De Gruttola Authors: G. Gatineau, G. Nguyen, K. Hind, M. Kužma, J. Payer, G. Guglielmi, A. Fahrleitner-Pammer and D. Hans
10:20
Auditorium A
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award René Rizzoli
10:30 - 12:10
Auditorium A
Scientific Session V Chairpersons : Charlotte Beaudart & Eugene V. McCloskey
10:30
Auditorium A
Presentation of the IOF Olof Johnell Science Award Eugene V. McCloskey
10:40
Auditorium A
Plenary Lecture 6 Management of osteoporosis in multi-ethnic societies Manju Chandran
Have a sneak peek
11:10
Auditorium A
Oral communications selected from abstracts
11:10
Auditorium A
Oral communication selected from abstracts OC24: VITAMIN D METABOLITE RATIO (VMR) OFFERS THE BEST APPROACH TO EVALUATE FUNCTIONAL VITAMIN D DEFICIENCY: RESULTS OF THE SARCOPHAGE STUDY Presenting author: E. Cavalier Authors: A. Ladang, A.-S. Gendebien, S. Kovacs, C. Demonceau, C. Beaudart, C. Le Goff, J.-Y. Reginster and O. Bruyère
11:20
Auditorium A
Oral communication selected from abstracts OC25: CALCITRIOL SUPPLEMENTATION AFTER KIDNEY TRANSPLANTATION: RESULTS OF A DOUBLE-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED TRIAL Presenting author: T. Nickolas Authors: P. Khairallah, S. Sammons, S. Agarwal, N. Cortez, M. Fusaro, M. Plebani, M. Zaninotto and C. Cosma
11:30
Auditorium A
Oral communication selected from abstracts OC26: FRACTURE LIAISON SERVICES AND SUBSEQUENT FRACTURE RISK: A MULTICENTER, PRAGMATIC, STEPPED-WEDGE CLUSTER-RANDOMIZED CONTROLLED TRIAL Presenting author: F. Frihagen Authors: C. Andreasen, C. Dahl, T. T. Borgen, T. Basso, J. E. Gjertsen, W. Figved, T. Wisløff, G. Hagen, E. M. Apalset, J. M. Stutzer, I. Lund, A. K. Hansen, F. I. Nissen, R. M. Joakimsen, U. Syversen, E. F. Eriksen, L. Nordsletten, T. K. Omsland, A. Bjørnerem and L. B. Solberg
11:40
Auditorium A
Oral communication selected from abstracts OC27: PROTON PUMP INHIBITORS ASSOCIATED WITH INCREASED BONE TURNOVER MARKERS: RESULTS OF A LARGE OBSERVATIONAL COHORT STUDY Presenting author: D. Fitzpatrick Authors: R. Lannon, E. Laird, M. Ward, L. Hoey, C. F. Hughes, J. J. Strain, C. Cunningham, H. Mc Nulty and K. Mc Carroll
11:50
Auditorium A
Oral communication selected from abstracts OC28: DISCONTINUATION OF BISPHOSPHONATES IN OLDER PEOPLE WITH COMPLEX HEALTH NEEDS: SELF-CONTROLLED CASE SERIES TO ASSESS FRACTURE RISK Presenting author: A. M. Jödicke Authors: D. Prieto-Alhambra, F. Dernie, A. Delmestri, T. Rathod-Mistry and E. H. Tan
12:15 - 13:45
Auditorium A
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

12:15 - 13:45
Auditorium B
Sponsored Lunch Satellite Symposium

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
Poster Area
Poster Viewing Session II
14:00 - 15:00
Auditorium B
Sponsored Educational Lecture

* See details on the Sponsored Satellite Symposia page

14:00 - 15:00
MR1
EUGMS-ESCEO Joint Symposium Improving fragility fracture care: a multidisciplinary perspective Chairperson : Tahir Masud
  • Optimizing fracture prevention and rehabilitation in frail older persons: the exercise & physiotherapy perspective Dawn Skelton
  • Optimizing fracture prevention and rehabilitation in frail older persons: the nursing & care home perspective Ellen Vlaeyen
14:00 - 15:00
MR2
OARSI-ESCEO Joint Symposium Managing Bone and Joint Diseases in Older Aged: Epidemiology and Lessons for the Clinic Chairpersons : Gun-il Im & Elizabeth M. Curtis
  • Immunometabolic Alterations Linking Diabetes Osteoarthritis and Osteoporosis Ali Mobasheri
  • Impact of Osteoporosis and Osteoarthritis as Comorbidities in the Aging Population Elaine M. Dennison
14:00 - 15:00
MR5
ESCEO Symposium ESCEO Working Group on “REMS in the diagnosis and management of osteoporosis: State of the art” Chairpersons : Radmila Matijevic & Andreas Kurth
  • REMS : How does it work and what do we measure? Adolfo Diez-Perez
  • What is the contribution of REMS to the management of post-menopausal osteoporosis? Nicholas Harvey
  • What is the contribution of REMS in the management of musculoskeletal health, outside of post-menopausal osteoporosis? Maria Luisa Brandi
  • Discussion All
14:00 - 15:00
Meet-The-Expert Session
14:00
MR4
Critical role of exercise in post fracture management Olivier Bruyère & Daniel Pinto
14:00
MR7
Transgender medicine: key challenges in the management of musculoskeletal disease Jean-Marc Kaufman
14:00
MR8
Achieving optimal musculoskeletal health in HIV Emmanuel Biver
14:00 - 15:00
Podium
Oral presentations of selected posters Chairperson : K. A. Ward
14:00
Podium
P1091 GUT MICROBIOTA AND SHORT-CHAIN FATTY ACID SIGNATURES IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS：A RETROSPECTIVE STUDY Presenting author: P. Sun Authors: S. Li, Y. Zhang, C. Ma and Q. Dong
14:06
Podium
P1122 EXPECTED LOSS OF PRODUCTIVITY FOLLOWING FRAGILITY FRACTURES IN PATIENTS OF WORKING AGE Presenting author: R. Pinedo-Villanueva Authors: J. Griffin, L. Wiggins, N. Nicola, C. Jones and K. M. Javaid
14:12
Podium
P228 THE ICARE FEASIBILITY STUDY: AN INTEGRATED COLLECTION OF EDUCATION MODULES FOR FALL AND FRACTURE PREVENTION FOR HEALTHCARE PROVIDERS IN LONG TERM CARE Presenting author: A. Papaioannou Authors: G. Ioannidis, L. Hillier, J. D. Adachi, A. Costa, G. Heckman, J. Hirdes, J. Holroyd-Leduc, S. Jaglal, S. Kaasalainen, A. Lau, C. McArthur, L. Kane, S. Marr, S. Straus, J.-E. Tarride, L. Thabane, M. Abbas and I. Rodrigues
14:18
Podium
P754 ANXIETY AND DEPRESSION ARE ASSOCIATED WITH POOR HEALTH BEHAVIOURS AND INCIDENT FRACTURE AMONG WOMEN: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY Presenting author: L. D. Westbury Authors: G. Bevilacqua, C. Cooper and E. M. Dennison
14:24
Podium
P863 BONE MINERAL DENSITY POST-TREATMENT FOLLOW-UP IN WOMEN WITH ENDOMETRIOSIS TREATED WITH RELUGOLIX COMBINATION THERAPY: SPIRIT PROGRAMME Presenting author: M. McClung Authors: N. Johnson, S. Ferrari, J. S. Perry, Y. Zhong and R. B. Wagman
14:30
Podium
P679 COMPARATIVE ANALYSIS OF TERIPARATIDE AND ROMOSOZUMAB IN PREVENTING SYMPTOMATIC SUBSEQUENT VERTEBRAL COMPRESSION FRACTURE AFTER CEMENTING Presenting author: J.-H. Jiann-Her Authors: W.-H. Kao, Y.-H. Chiang, W.-C. Lo and M.-H. Wu
14:36
Podium
P1136 STANDARD X-RAY IMAGES MAY POTENTIALLY BE USED TO QUANTIFY BONE DISORGANIZATION AND IDENTIFY PATIENTS WITH HYPOPHOSPHATASIA Presenting author: R. Zebaze Authors: C. Shore-Lorenti, Z. Simon, K. Djopseu, T. Makebeh, F. Milat and P. R. Ebeling
14:42
Podium
P280 ASSESSMENT OF ADHERENCE TO ANTI-OSTEOPOROTIC MEDICATION (AOM) TREATMENT IN THE RISK-STRATIFIED OSTEOPOROSIS STRATEGY EVALUATION (ROSE) SCREENING PROGRAMME: A TEN-YEAR FOLLOW-UP STUDY Presenting author: B. Abrahamsen Authors: T. G. Petersen, K. H. Rubin, K. M. Javaid, A. P. Hermann and K. E. Akesson
14:48
Podium
P1013 THE EFFECT OF EIGHT MONTHS OF BALLISTIC AND CONVENTIONAL RESISTANCE EXERCISE TRAINING ON BONE STRENGTH IN POSTMENOPAUSAL WOMEN: THE REPROOF STUDY Presenting author: O. Caliskan Authors: E. A. Marques, J. P. Folland and K. Brooke-Wavell
14:54
Podium
P142 CALCIUM (CA) ISOTOPE COMPOSITION IN SERUM AND URINE FOR THE ASSESSMENT OF BONE CALCIUM BALANCE (BCAB) – RESULTS FROM A POST-MARKET SURVEILLANCE CLINICAL FOLLOW-UP STUDY ON 2409 PARTICIPANTS Presenting author: A. Eisenhauer Authors: A. Heuser, J. Oehme, M. Lutz and M. Müller
15:00 - 17:00
Auditorium A
Scientific Session VI Chairpersons : Jean-Yves Reginster & Radmila Matijevic
15:00
Auditorium A
Plenary Lecture 7 How should we define sarcopenia? Past, present and future perspectives Alfonso J. Cruz-Jentoft
Have a sneak peek
15:30
Auditorium A
Oral communications selected from abstracts
15:30
Auditorium A
Oral communication selected from abstracts OC29: GLOBAL BALANCE OF THE SPINE, AN INDEPENDENT CONTRIBUTOR TO PHYSICAL IMPAIRMENTS AND PREDICTOR OF INCIDENT FALLS IN OLDER ADULTS: THE SAFE 3-YEAR LONGITUDINAL COHORT STUDY Presenting author: A. Trombetti Authors: M. Hars, A. Faundez, M.-J. Begin, M. Terrien Ferey, J. Fechtenbaum, K. Briot, C. Roux, F. Herrmann, C. Graf, S. Ferrari, S. Genevay and S. Boudabbous
15:40
Auditorium A
Oral communication selected from abstracts OC30: A NOVEL DRUG COMBINATION WITH THERAPEUTIC POTENTIAL FOR SARCOPENIA Presenting author: A. Beliën Authors: E. Mercken, J. Frickel, S. Huettner, J.-Y. Reginster, C. Tezze and M. Sandri
15:50
Auditorium A
Oral communication selected from abstracts OC31: IMMINENT FRACTURE RISK AND MORTALITY DIFFER BY INDEX FRACTURE SITE AND BONE MINERAL DENSITY Presenting author: K. M. Javaid Authors: R. Pinedo-Villanueva and W. D. Leslie
16:00
Auditorium A
Oral communication selected from abstracts OC32: EFFECT OF FRAXPLUS ADJUSTMENTS ON FRACTURE RISK RECLASSIFICATION IN OLDER SWEDISH WOMEN – RESULTS FROM THE SUPERB-STUDY Presenting author: M. Zoulakis Authors: H. Johansson, N. Harvey, K. F. Axelsson, H. Litsne, L. Johansson, E. Liu, M. Schini, L. Vandenput, E. V. McCloskey, J. A. Kanis and M. Lorentzon
16:10
Auditorium A
Oral communication selected from abstracts OC33: SMOKING HISTORY AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL Presenting author: H. Johansson Authors: M. Schini, N. Harvey, M. Lorentzon, E. Liu, L. Vandenput, J. A. Kanis, E. V. McCloskey and The Frax Meta-Analysis Cohort
16:20
Auditorium A
Oral communication selected from abstracts OC34: QUANTITATIVE MOTION ARTEFACT GRADING IN HR-PQCT CLINICAL IMAGING: AN ALGORITHMIC APPROACH Presenting author: T. Cox Authors: S. Mahmoodi, L. D. Westbury, N. R. Fuggle, S. Lu and N. Harvey
16:30
Auditorium A
Plenary Lecture 8 Sarcopenia management: muscle-targeted interventions for healthy ageing Antonio Cherubini
Have a sneak peek
15:00 - 16:45
MR5
Committee of Scientific Advisors Special Session IOF CSA Special Session 2024: Hip fracture to marrow adiposity and hypophosphatasia: advances in understanding skeletal disease Chairpersons : Nicholas Harvey & Eugene V. McCloskey
  • Optimisation of hip fracture services: lessons from the REDUCE Study Celia L. Gregson
  • Bone marrow adiposity: new understanding in osteoporosis pathogenesis Julien Paccou
  • State-of-the-art in hypophosphatasia: recent recommendations from international working groups Maria Luisa Brandi
17:00 - 18:00
Non-Sponsored Symposia
17:00
MR1
How to write a good review article Chairpersons : Olivier Bruyère & Nasser Al-Daghri
  • How to write a narrative review Shaun Sabico
  • How to write a systematic review and meta-analysis Germain Honvo
  • How to write an umbrella review Nicola Veronese
17:00
MR2
Understanding exercise for osteoporosis Chairperson : Belinda R. Beck
  • The principles of osteogenic loading Katherine Brooke-Wavell
  • Translation of osteogenic principles into effective exercise prescription Belinda R. Beck
17:00
MR3
Information and knowledge impact risk perception and awareness of musculoskeletal diseases – a path toward effectiveness Chairperson : Fatjona Kamberi
  • Knowledge, risk perception, and impact on engagement in the prevention of musculoskeletal diseases – the focus group on Vitamin D Fatjona Kamberi
  • Self-education in chronic patients with musculoskeletal conditions Doreada Mio
  • Physiotherapy in Osteoporosis. Practice behaviors and Physiotherapists’ perceptions in Albania Enkeleda Sinaj
  • Evaluation of Knowledge on the Impact of Vitamin D on Osteoarthritis Glodiana Sinanaj
17:00
MR4
Primary hyperparathyroidism as a cause of osteoporosis. Diagnosis and management Chairpersons : Panagiotis Athanassiou & Ifigenia Kostoglou-Athanassiou
  • Primary hyperparathyroidism. Etiology and clinical manifestations Ifigenia Kostoglou-Athanassiou
  • Primary hyperparathyroidism and psychological implications Yannis Athanassiou
  • Primary hyperparathyroidism and muscular effects Lambros Athanassiou
  • Primary hyperparathyroidism and osteoporosis. The role of exercise Yannis Dionyssiotis
  • Primary hyperparathyroidism and osteoporosis. Management Panagiotis Athanassiou
17:00
MR5
Osteoporosis treatment beyond 10 years Chairperson : Bruno Muzzi Camargos
  • Long-term treatment of Osteoporosis: What’s up on 10-years after Geraldine Altamar Canales
  • Discontinuation of Anti-Osteoporosis Treatments: Should we do it, when and how Adriana Medina-Orjuela
  • Recommendations for Osteoporosis treatment beyond 10 years Andrès Felipe Coy Barrera
17:00
MR6
Bone health and vitamin D metabolism in chronic rheumatic diseases. Fibromyalgia and bone. Chairpersons : Willem Lems & Osvaldo Daniel Messina
  • Chronic arthritides and Bone Hennie G. Raterman
  • Vitamin D in patients with inflammatory rheumatic diseases Willem Lems
  • Fibromyalgia and bone Osvaldo Daniel Messina
17:00
MR7
How to optimize bone health in athletes? Chairperson : Sansin Tüzün
  • Scope of the Problem: Beyond the Female Athlete Triad Sansin Tüzün
  • Assessment of Bone Strength in Athletes John Carey
  • How can REMS be helpful to assess bone in Sports Medicine? Radmila Matijevic
  • How to Manage Bone Loss in Athletes? Rana Terlemez
17:00
MR8
Platelet-rich plasma in musculoskeletal pathologies Chairperson : Jean-François Kaux
  • Qualitative aspects of platelet-rich plasma injections Jean-François Kaux
  • Nerve anaesthesia for painful platelet-rich plasma injection Loïc Chimot
  • Post-procedure after platelet-rich plasma injection for a tendinopathy Martin Lamontagne

Sunday April 14th - GMT Time zone

08:00 - 09:00
Non-Sponsored Symposia
08:00
MR2
Sarcopenia in metabolic and neurological diseases Chairpersons : Panagiotis Athanassiou & Yannis Dionyssiotis
  • Introduction in Sarcopenia Panagiotis Athanassiou
  • Sarcopenia in Metabolic Diseases Ifigenia Kostoglou-Athanassiou
  • Sarcopenia in Diabetes Mellitus Yannis Dionyssiotis
  • Sarcopenia in Neurological Disorders Yannis Dionyssiotis
08:00
MR3
Neurocardiovascular disease and osteoporosis: recently met or a long relationship? Chairperson : Geraldine Altamar Canales
  • Osteoporosis and cardiovascular risk: old friends? Adriana Medina-Orjuela
  • Osteoporosis and dementia: where are we going? Geraldine Altamar Canales
  • Treatments for osteoporosis and cardiovascular events: what do we know? Alejandro Román-González
08:00
MR4
Managing pregnancy-and lactation-associated osteoporosis Chairpersons : Maria Luisa Brandi & Nicholas Harvey
  • Bone fragility and osteoporosis in young adults Lothar Seefried
  • Assessment of bone health in pregnancy Valentina Degennaro
  • Management of bone fragility in pregnant women Maria Luisa Brandi
08:00
MR6
Bone health solutions: maybe it’s time for a change? Chairperson : P. Dean Cummings
  • The Critical Shift to a Proactive Approach to Bone Health P. Dean Cummings
  • Optimal Clinical Paradigm: 4-Pillar Evaluation, Integrated Profile, and Multidisciplinary Care Plan Rachel Patel
  • Bone Health Solutions P. Dean Cummings
08:00
MR7
Navigating heterogeneity in vitamin D supplementation: implications for regional health - a Latin American perspective Chairperson : José Francisco Torres Naranjo
  • Vitamin D Status and Diverse Medical Practices in Mexico and Latin America Pedro Alberto García Hernández
  • Global and Regional Dynamics: Heterogeneity in Vitamin D Supplementation Across Latin America Hugo Gutierrez-Hermosillo
  • Formulating Unity: Mexico's Approach to the National Joint Position José Francisco Torres Naranjo
08:00
MR8
Fractures-E3 study: fractures in Sub-Saharan Africa – epidemiology, ethnography and economic impact Chairpersons : Tereza Hough & Tafadzwa Madanhire
  • The impact of menopause and HIV on midlife bone health Tafadzwa Madanhire
  • The challenges of poor musculoskeletal health in The Gambia Kate A. Ward
  • Hip fracture incidence and outcomes in Zimbabwe Celia L. Gregson
  • The economic impact of hip fracture in Zimbabwe and South Africa Nyasha Mafirakureva
08:00 - 09:00
MR5
SICOT-ESCEO-IOF Symposium Surgical Treatment of Fragility Fractures Chairperson : Ilir Hasani
  • Osteoporotic Spine Fractures Giuseppe Lambros Morassi
  • Trends in the management of osteoporotic pelvic fractures Michel Paul Johan Teuben
  • Will a treatment Protocol including OF classification provide clear guidelines for osteoporotic thoracolumbar fracture management? Can we avoid overtreatment or undertreatment? Neda Trajkovska
  • Osteoporotic Hip Fracture Ilir Hasani
  • Discussion
09:00 - 10:00
Meet-The-Expert Session
09:00
MR3
Denosumab cessation: a practical approach in long-term treatment Elizabeth M. Curtis
09:00
MR4
Quality of life assessment in sarcopenia - Lessons for cohort and clinic Charlotte Beaudart
09:00
MR5
Phosphate wasting for the osteoporosis doctor Judith Bubbear
09:00
MR6
Management of GIOP in Latin America Osvaldo Daniel Messina
09:00 - 10:00
Poster Area
Poster Viewing Session III
10:00 - 12:00
Auditorium A
Scientific Session VII Chairpersons : Salvatore Minisola & Etienne Cavalier
10:00
Auditorium A
Plenary Lecture 9 New perspectives in osteoarthritis management Ali Mobasheri
Have a sneak peek
10:30
Auditorium A
Presentation of the ESCEO-IOF Young Investigator Awards Nicholas Harvey
10:40
Auditorium A
Oral communications selected from abstracts
10:40
Auditorium A
Oral communication selected from abstracts OC35: FRACTURE RATE AND LOCATION IN ADULTS WITH HYPOPHOSPHATASIA WITH ONE VERSUS MULTIPLE ALPL VARIANTS: DATA FROM THE GLOBAL HPP REGISTRY Presenting author: L. Seefried Authors: K. Dahir, G. Martos-Moreno, K. Ozono, W. Högler, C. Rockman-Greenberg, S. Fang, A. Petryk, P. Kishnani and A. Linglart
10:50
Auditorium A
Oral communication selected from abstracts OC36: IS THERE AN ASSOCIATION BETWEEN BIRTH WEIGHT OR GESTATIONAL AGE AND FRACTURE RISK IN YOUNG ADULTS? Presenting author: H. T. Holltrø Authors: T. I. L. Nilsen, B. Schei, I. Tronstad, A. Langhammer and M. Hoff
11:00
Auditorium A
Oral communication selected from abstracts OC37: AIR POLLUTION AND BONE HEALTH OUTCOMES: PERIODS OF SUSCEPTIBILITY FROM PREGNANCY TO CHILDHOOD Presenting author: L. Scheepers Authors: A. C. Binter, S. Santos, S. Petricola, F. Rivadeneira, V. Jaddoe, M. Guxens and F. Johnston
11:10
Auditorium A
Oral communication selected from abstracts OC38: FAMILY HISTORY OF FRACTURE AND FRACTURE RISK: A META-ANALYSIS TO UPDATE THE FRAX® RISK ASSESSMENT TOOL Presenting author: E. V. McCloskey Authors: H. Johansson, E. Liu, M. Schini, L. Vandenput, N. Harvey, M. Lorentzon, W. D. Leslie, J. A. Kanis and The Frax Meta-Analysis Cohort
11:20
Auditorium A
Oral communication selected from abstracts OC39: SEX DEPENDENT ASSOCIATIONS BETWEEN BMI AND FRACTURE RISK: AN INTERNATIONAL META-ANALYSIS Presenting author: N. Harvey Authors: H. Johansson, E. V. McCloskey, E. Liu, M. Schini, L. Vandenput, M. Lorentzon, W. D. Leslie, J. A. Kanis and The Frax Meta-Analysis Cohort
11:30
Auditorium A
Plenary Lecture 10 Precision medicine approaches in the assessment of fracture risk Nicholas Harvey
Have a sneak peek
12:00 - 13:00
Non-Sponsored Symposia
12:00
MR1
Patient and public involvement and engagement (PPI/E) in musculoskeletal research: an idea whose time has firmly come (and we are sharing the resources to help you get started) Chairperson : Angie Botto-van Bemden
  • WHY; Introduction to PPI, overview of impact and progress Adewale Adebajo
  • WHAT; PPI Article Collection as a global resource Ciaran Fitzpatrick
  • HOW; Implementing patient partnerships Maarten De Wit
  • WHERE we are going; PPI opportunities Angie Botto-van Bemden
12:00
MR2
Hyperthyroidism and osteoporosis Chairperson : Ifigenia Kostoglou-Athanassiou
  • Hyperthyroidism. Etiology and clinical manifestations Ifigenia Kostoglou-Athanassiou
  • Hyperthyroidism. Psychosocial implications Yannis Athanassiou
  • Hyperthyroidism and sarcopenia Lambros Athanassiou
  • Hyperthyroidism and osteoporosis. Pathophysiology and management Panagiotis Athanassiou
12:00
MR3
Bone health and the spine: opportunities to drive public and health care professional education and action Chairperson : Rita Roy
  • Osteoporosis and the Spine: Key Statistics and an Overview of the National Spine Health Foundation’s Key Patient and Health Care Professional Initiatives Thomas Schuler
  • A Spine Surgeon Perspective on the Need for Perioperative Spine and Bone Health Optimization Paul Anderson
  • Spine and Bone Health Patient Educational Gaps and Needs Rita Roy
  • A European Perspective on Key Spine Surgeon Gaps in the Diagnosis and Treatment of Osteoporotic Patients Elie Najjar
12:00
MR4
Glucocorticoids in the treatment of rheumatoid arthritis. Friend or foe? Chairpersons : Osvaldo Daniel Messina & Giovanni Adami
  • GCS in the treatment of rheumatoid arthritis. Friends Osvaldo Daniel Messina
  • Glucocorticoids “foe” Giovanni Adami
12:00
MR5
Clinical conundrums – bone health management in special scenarios Chairperson : Muhammad Nisar
  • Managing eGFR and bone Richard Keen
  • Managing Aromatase inhibitor induced bone loss Muhammad Nisar
12:00
MR6
Osteoporosis and cardiovascular disease: new insight Chairperson : Sekib Sokolovic
  • Osteocalcin: Old-New Marker- Can it be prognostic for CVD? Blazenka Miskic
  • The Hidden upstairs between Bone density and Cardiovascular Mortality Hassan Bassiouni
  • Osteoporosis and Cardiovascular Diseases: A case-series study Sekib Sokolovic
12:00
MR7
Fracture prevention strategies and antiosteoporotic medications in elderly population Chairpersons : Pınar Borman & Belgin Karaoglan
  • Prevention of Hip Fractures Burcu Duyur Çakit
  • Antiosteoporotic Agents and Fracture Healing Pınar Borman
  • Rehabilitation of Hip Fractures Aysegul Yaman
12:00
MR8
Osteoporosis: impact on health & economics Chairpersons : Yasser El Miedany & Mathias Toth
  • Health Economics of Osteoporosis: The missed interventional threshold Yasser El Miedany
  • Direct cost of osteoporotic Hip fractures Walaa El Wakil
  • Economic Evaluation of FLS in Egypt Mathias Toth